RED SPRUCE CAPITAL, LLC – Neurocrine Biosciences, Inc. Transaction History
RED SPRUCE CAPITAL, LLC portfolio value:
$1.61M
portfolio value
RED SPRUCE CAPITAL, LLC quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.80% | 121 shares | 145K | $106.21 | 15.20K |
| Q2 2022 | share | Increase | +1.53% | 228 shares | 77K | $97.48 | 15.08K |
| Q1 2022 | share | Increase | +14.80% | 1.91K shares | 291K | $93.75 | 14.85K |
| Q4 2021 | share | Increase | +10.16% | 1.19K shares | -25K | $84.63 | 12.93K |
| Q3 2021 | share | Decrease | -0.89% | -105 shares | -26K | $95.91 | 11.74K |
| Q2 2021 | share | 0.00% | 0 shares | 0 | $97.32 | 11.85K | |
| Q1 2021 | share | Increase | +2.46% | 285 shares | 44K | $97.25 | 11.85K |
| Q4 2020 | share | Increase | +3.79% | 422 shares | 37K | $95.85 | 11.56K |
| Q3 2020 | share | Increase | +12.46% | 1.23K shares | -137K | $96.16 | 11.14K |
| Q2 2020 | share | Increase | +0.36% | 36 shares | 354K | $122 | 9.90K |
| Q1 2020 | share | Decrease | -0.53% | -53 shares | -212K | $86.55 | 9.87K |
| Q4 2019 | share | Increase | 0.00% | 9.92K shares | 1.06M | $107.49 | 9.92K |